Drug Type Antibody drug conjugate (ADC) |
Synonyms AGS 67E, AGS67E |
Target |
Mechanism CD37 antagonists(Leukocyte antigen CD37 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC11H22N4O4 |
InChIKeyAGGWFDNPHKLBBV-YUMQZZPRSA-N |
CAS Registry159858-33-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 1 | US | 29 Mar 2016 | |
Acute Myeloid Leukemia | Phase 1 | CA | 29 Mar 2016 | |
Lymphoma | Phase 1 | US | 14 Oct 2014 | |
Lymphoma | Phase 1 | CA | 14 Oct 2014 |
Phase 1 | 30 | pvmoysqync(jlqzhblbvo) = Gr 4 neutropenia 8 - 15 days after 1st dose vrupsvkzqa (snkfmfmtkc ) | Positive | 20 May 2016 |